Skip to content

UPDATED 15:09 EDT / JULY 24 2026

Ron Alfa, Co-founder and CEO of Noetik — theCUBE + NYSE Wired AI in Bio 2026 2

by Cheryl Knight

Ron Alfa, Co-founder and CEO of Noetik, talks to theCUBE about how AI is reshaping biotech and raising the odds of clinical success, at theCUBE + NYSE Wired: AI in Bio 2026.

Ron Alfa, Co-founder and CEO of Noetik — theCUBE + NYSE Wired AI in Bio 2026 2
Photo: SiliconANGLE

Send us a news tip

Send us a News Tip

  • This field is for validation purposes and should be left unchanged.

Sign in or create an account

SIGN IN

Forgot Password?

OR

New User? SIGN UP

Join us

SIGN UP

Bio

Ethics statement

Extract the signal from the noise

Get SiliconANGLE updates and analysis.

Contact us

Partner with us

Contact us

Guest inquiry